Table 2. MESNA with Hydration Evidence.
First Author, Year Study Design | Subjects | Findings | GRADE quality level |
---|---|---|---|
Hows, 1984 RCT | 61 SCT adult patients | Mesna plus 3 liters of IV hydration daily during CTX is more effective for HC than 6 liters of IV hydration plus diuresis (p<0.05) | Moderate |
Shepard, 1991 RCT | 100 adult patients with cancer | No difference between mesna plus 1.5 liters/m2/day of IV fluids compared to 3 liters/m2/day of IV fluids plus lasix for severe HC (p=0.71) | High |
Khojasteh, 2000 Case study | 18 pediatric and young adults with leukemia or hematological disease | Adding mesna with IV fluids at 3 liters/m2/day is effective in preventing HC | Low |
Murphy, 1993 Retrospective | 217 adult patients with cancer | No HC prevalence difference between IV hydration at 3.6 liters/m2/day compared to same IV hydration plus mesna | Moderate |
Marshall, 2011 Case study | 1 adult patient with breast cancer | CTX without hydration caused HC but mesna plus IV hydration given with subsequent CTX with no HC | Very Low |
Monarch, 2010 Systematic review | 38 articles | No HC prevalence difference between IV hydration at 3 liters/m2/day compared to IV hydration of 1.5-3 liters/day plus mesna | Moderate |
Schuchter, 2002 Clinical guideline | Update of the 1999 chemotherapy and radiotherapy protectants clinical guideline by ASCO; mesna plus saline diuresis or forced saline diuresis is recommended for high dose CTX | Not applicable | |
Damron, 2009 Systematic Review | 54 articles | Mesna plus saline diuresis or forced diuresis with high dose CTX | High |
Abbreviations: RCT = randomized control trial; SCT = stem cell transplant; IV = intravenous; CTX = Cytoxan; HC = hemorrhagic cystitis; ASCO = American Society of Clinical Oncology